flumazenil and mrk 016

flumazenil has been researched along with mrk 016 in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bagal, SK; Brown, AD; Cox, PJ; Omoto, K; Owen, RM; Pryde, DC; Sidders, B; Skerratt, SE; Stevens, EB; Storer, RI; Swain, NA	1
Agrawal, NG; Atack, JR; Burns, HD; Chambers, MS; Dawson, GR; Eng, WS; Evans, DC; Gibson, RE; Gingrich, K; Hargreaves, RJ; Hostetler, E; Krause, S; MacLeod, AM; Maubach, KA; McKernan, RM; Murphy, MG; Musson, DG; O'Connor, D; Petty, KJ; Rodrigues, AD; Ryan, C; Sanabria, SM; Tattersall, FD; Wafford, KA	1

Reviews

1 review(s) available for flumazenil and mrk 016

Article	Year
Ion channels as therapeutic targets: a drug discovery perspective. Journal of medicinal chemistry, 2013, Feb-14, Volume: 56, Issue:3 Topics: Drug Discovery; Humans; Ion Channels; Models, Molecular; Phylogeny	2013

Other Studies

1 other study(ies) available for flumazenil and mrk 016

Article	Year
In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor alpha5 subtype-selective inverse agonist. The Journal of pharmacology and experimental therapeutics, 2009, Volume: 331, Issue:2 Topics: Animals; Anxiety; Behavior, Animal; Convulsants; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Electrophysiology; Excitatory Postsynaptic Potentials; Fibroblasts; Flumazenil; GABA Agonists; GABA Modulators; GABA-A Receptor Agonists; Hepatocytes; Hippocampus; Humans; Isoxazoles; Macaca mulatta; Male; Maze Learning; Mice; Patch-Clamp Techniques; Postural Balance; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Triazines; Young Adult	2009

Article

Year

In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor alpha5 subtype-selective inverse agonist.

The Journal of pharmacology and experimental therapeutics, 2009, Volume: 331, Issue:2

Topics: Animals; Anxiety; Behavior, Animal; Convulsants; Dogs; Dose-Response Relationship, Drug; Electric Stimulation; Electrophysiology; Excitatory Postsynaptic Potentials; Fibroblasts; Flumazenil; GABA Agonists; GABA Modulators; GABA-A Receptor Agonists; Hepatocytes; Hippocampus; Humans; Isoxazoles; Macaca mulatta; Male; Maze Learning; Mice; Patch-Clamp Techniques; Postural Balance; Rats; Rats, Sprague-Dawley; Receptors, GABA-A; Triazines; Young Adult

2009